BXP Beximco Pharmaceuticals PLC.

0.7562USD57.50 GBp · LSE0.00%Mkt Cap: 337.35M USDP/E: 4.79

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and an…

Key Statistics

Company
Market Cap337.35M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit22.30B BDT
Net Income (TTM)6.94B BDT
Revenue/Share—
Last Price0.7562 USD
Fiscal Year EndJun 2026
MR QuarterSep 2026
Employees6.0K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS0885792061
Valuation
P/E (Trailing)4.79
P/E (Forward)0.07
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.01
EPS (TTM)0.12 BDT
EPS (Forward)8.14 BDT
52W Range
0.482773% of range0.8548
52W High0.8548 USD
52W Low0.4827 USD
Profitability
Gross Margin45.39%
Oper. Margin0.00%
EBITDA Margin23.88%
Profit Margin14.13%
ROE13.07%
ROA9.48%
ROIC12.58%
ROCE14.83%
Growth
Revenue Growth6.30%
Earnings Growth8.00%
Cash Flow & Leverage
Operating CF7.22B BDT
CapEx (TTM)3.03B BDT
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio4.82
Quick Ratio1.97
Book Value/Sh111.35 BDT
Cash/Share—
Dividends
Fwd Div Rate0.0005 USD
Trail. Div Rate0.00 USD
Div. Yield6.36%
5Y Avg Yield5.37%
Payout Ratio0.00%
Ex-Div DateNov 18, 2026
Pay Date—
Splits
Last Split110:100
Split DateNov 23, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.446.11M
Float—
Insiders0.00%
Institutions0.21%
Technical
SMA 500.7442 (+1.6%)
SMA 2000.3980 (+90.0%)
Beta0.28
S&P 52W Chg12.00%
Avg Vol (30d)20.25K
Avg Vol (10d)23.97K
Technical Indicators
RSI (14)52.5
MACD1.0702
MACD Signal0.9796
MACD Hist.+0.0906
BB Upper0.8398 USD
BB Middle0.7414 USD
BB Lower0.6430 USD
BB Width26.55%
ATR (14)0.0353 USD
Vol Ratio (20d)1.40x

About Beximco Pharmaceuticals PLC. (LON: BXP)

›

Beximco Pharmaceuticals PLC. (LON: BXP) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 6,000 employees.

The shares were at 57.50 GBp on 19 November 2026, up 37.0% over 52 weeks. Its 52-week range is 36.70 GBp to 65.00 GBp: the price is 11.5% below the high and 56.7% above the low.

At a market capitalisation of 256.51M GBP, it trades at 4.8 times trailing earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 81% for BXP. It pays a dividend yielding 6.36%, against a median of 1.90% among the dividend payers in that peer group.

Beximco Pharmaceuticals PLC. reports return on equity of 13.1%, an operating margin of 0.0% and revenue up 6.3% year over year.

Its Piotroski F-score is 9 out of 9, a strong reading of its financial health.